As shown in Figure 2A and 2B and in Supplementary Figure S2A, gemcitabine up-regulated HAb18G/CD147 protein expression in a dose-dependent manner in both pancreatic cancer cell lines, with the maximal enhancement occurring at 10 μM gemcitabine. The gene discussed is BSG; the disease is pancreatic neoplasm.